2024 Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Chemotherapy Read more
2024 Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications Read more
2024 An evaluation of novel oncology approvals with a PMR/C for assessing data in racial and ethnic populations underrepresented in premarket clinical trials Read more
2024 Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages Read more
2024 Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products Read more
2024 Improving Equity in Oncology Clinical Trials: Challenges and Strategies for Setting Diversity Enrollment Goals View PDF
